JOHNSON & JOHNSON DEVELOPMENT CORPORATION
Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators, health care trends, and strategic investment opportunities. Unlike traditional venture capital firms, JJDC determines the success of an investment’s performance not only in financial returns, but also in the viability of providing strategic growth options for ... Johnson & Johnson. JJDC plays an integral role in the identification of new business opportunities outside of Johnson & Johnson’s traditional portfolio and market presence. JJDC identifies new market opportunities and develops new businesses in emergent health care sectors while also creating support venture investments in alignment with the strategic objectives of Johnson & Johnson operating companies.
JOHNSON & JOHNSON DEVELOPMENT CORPORATION
Industry:
Biotechnology Consumer Health Care Medical Device Pharmaceutical
Founded:
1979-01-01
Status:
Closed
Contact:
(514) 367 1212
Email Addresses:
[email protected]
Technology used in webpage:
Euro Amazon Amazon Virginia Region Pound Sterling
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-08 | Osteal Therapeutics | Johnson & Johnson Development Corporation investment in Series B - Osteal Therapeutics | 30 M USD |
| 2021-05-27 | Binx Health | Johnson & Johnson Development Corporation investment in Series E - Binx Health | 104 M USD |
| 2020-07-07 | CVRx | Johnson & Johnson Development Corporation investment in Private Equity Round - CVRx | 50 M USD |
| 2019-08-09 | CVRx | Johnson & Johnson Development Corporation investment in Series G - CVRx | 93 M USD |
| 2017-03-01 | Grail | Johnson & Johnson Development Corporation investment in Series B - Grail | 1.21 B USD |
| 2017-02-23 | Fusion Pharmaceuticals | Johnson & Johnson Development Corporation investment in Series A - Fusion Pharmaceuticals | 25 M USD |
| 2016-11-10 | ReVision Optics | Johnson & Johnson Development Corporation investment in Venture Round - ReVision Optics | 32 M USD |
| 2016-02-16 | Cala Health | Johnson & Johnson Development Corporation investment in Series B - Cala Health | 18 M USD |
| 2015-03-12 | PhaseBio Pharmaceuticals | Johnson & Johnson Development Corporation investment in Series C - PhaseBio Pharmaceuticals | 40 M USD |
| 2015-01-21 | Willow | Johnson & Johnson Development Corporation investment in Series A - Willow | 15 M USD |